← PDS Biotechnology (PDSB)

PDS Biotechnology SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 4Oct. 21, 2026, 6:41 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 7:59 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedPDS Biotechnology posts updated corporate presentation (Exhibit 99.1) with no new financial results, highlighting PDS0301 data and five readouts through Q2 2028

  • 4Oct. 20, 2026, 8:20 p.m. ETView on SEC.gov
  • 4Oct. 20, 2026, 8:20 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 8 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Other events · Financial statements and exhibits

    AI summary, unreviewedPDS Biotechnology Corp board overhaul: four directors resign, three pharma executives appointed, no financial results disclosed

  • 8-KOct. 6, 2026, 8:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 8-KSept. 22, 2026, 8:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • SCHEDULE 13DSept. 21, 2026, 9:56 p.m. ETView on SEC.gov
  • 8-KSept. 21, 2026, 4:05 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 8-KSept. 14, 2026, 4:10 p.m. ETView on SEC.gov

    Termination of a material definitive agreement · Departure/appointment of directors or officers · Regulation FD disclosure · Other events · Financial statements and exhibits

  • 8-KSept. 8, 2026, 8:35 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits

  • 8-KSept. 4, 2026, 5:25 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Financial statements and exhibits

  • 8-KAug. 25, 2026, 4:08 p.m. ETView on SEC.gov

    Costs of exit or disposal activities · Departure/appointment of directors or officers

  • 8-KAug. 19, 2026, 4:52 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

  • 8-KAug. 14, 2026, 8 a.m. ETView on SEC.gov

    Amendments to articles or bylaws; fiscal year change · Submission of matters to a vote of security holders · Financial statements and exhibits

  • 10-QAug. 13, 2026, 4:20 p.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 8:35 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • 8-KAug. 11, 2026, 8:30 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 8-KJuly 31, 2026, 4:15 p.m. ETView on SEC.gov

    Delisting notice / failure to meet listing standard